Biocon Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BIOCON PHARMA, and what generic and branded alternatives to BIOCON PHARMA drugs are available?
BIOCON PHARMA has sixteen approved drugs.
Summary for Biocon Pharma
US Patents: | 0 |
Tradenames: | 15 |
Ingredients: | 15 |
NDAs: | 16 |
Patent Litigation for Biocon Pharma: | See patent lawsuits for Biocon Pharma |
PTAB Cases with Biocon Pharma as petitioner: | See PTAB cases with Biocon Pharma as petitioner |
Drugs and US Patents for Biocon Pharma
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Biocon Pharma | ATORVASTATIN CALCIUM | atorvastatin calcium | TABLET;ORAL | 216436-002 | Nov 23, 2022 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Biocon Pharma | ATORVASTATIN CALCIUM | atorvastatin calcium | TABLET;ORAL | 216436-001 | Nov 23, 2022 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Biocon Pharma | MICAFUNGIN SODIUM | micafungin sodium | INJECTABLE;INTRAVENOUS | 216438-001 | May 29, 2024 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Biocon Pharma | EVEROLIMUS | everolimus | TABLET;ORAL | 214182-004 | Feb 11, 2021 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Biocon Pharma | POSACONAZOLE | posaconazole | TABLET, DELAYED RELEASE;ORAL | 214476-001 | Feb 4, 2022 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.